A research team led by Professor Yasuharu Ota of the Graduate School of Medicine, Yamaguchi University, has published a paper in the prestigious journal Endocrine Journal (June 3, 2025), based on research utilizing NMN from Mirailab Bioscience Inc.
The study revealed that even a single administration of NMN can improve systemic insulin sensitivity. This finding suggests a potential new therapeutic approach for metabolic disorders such as metabolic syndrome, which are often associated with aging and obesity.
You can access the paper (in English) via the following link
⇒ https://doi.org/10.1507/endocrj.EJ24-0312
For further details about this study (original Japanese text), please refer to the press release from Yamaguchi University.
⇒ https://www.yamaguchi-u.ac.jp/weekly/41465/index.html